Abdo A. Elfiky

5.8k total citations · 4 hit papers
100 papers, 4.1k citations indexed

About

Abdo A. Elfiky is a scholar working on Molecular Biology, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Abdo A. Elfiky has authored 100 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 39 papers in Infectious Diseases and 26 papers in Computational Theory and Mathematics. Recurrent topics in Abdo A. Elfiky's work include Computational Drug Discovery Methods (26 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and Endoplasmic Reticulum Stress and Disease (17 papers). Abdo A. Elfiky is often cited by papers focused on Computational Drug Discovery Methods (26 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and Endoplasmic Reticulum Stress and Disease (17 papers). Abdo A. Elfiky collaborates with scholars based in Egypt, Saudi Arabia and Yemen. Abdo A. Elfiky's co-authors include Ibrahim M. Ibrahim, Wael M. Elshemey, Mohammed El-Shahat, Alaa M. Ismail, Jameel M. Abduljalil, Muhammad Ali, Azhar Rasul, Şevki Adem, Volkan Eyüpoğlu and Sayed M. Riyadh and has published in prestigious journals such as The Journal of Physical Chemistry B, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Abdo A. Elfiky

97 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

2020 698 citations Abdo A. Elfiky Life Sciences profile →
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

2020 530 citations Abdo A. Elfiky Life Sciences profile →
GRP78: A cell's response to stress

2019 474 citations Ibrahim M. Ibrahim, Abdo A. Elfiky et al. Life Sciences profile →
COVID-19 spike-host cell receptor GRP78 binding site prediction

2020 386 citations Ibrahim M. Ibrahim, Abdo A. Elfiky et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdo A. Elfiky Egypt	26	2.1k	1.2k	1.1k	438	414	100	4.1k
Wu Zhong China	27	2.5k 1.2×	1.4k 1.2×	1.1k 0.9×	673 1.5×	123 0.3×	116	5.4k
Rituraj Purohit India	52	697 0.3×	3.1k 2.7×	1.3k 1.1×	251 0.6×	497 1.2×	157	5.5k
Ute Curth Germany	23	1.3k 0.6×	2.0k 1.8×	1.4k 1.2×	143 0.3×	282 0.7×	45	3.9k
Yang Xu China	24	1.3k 0.6×	1.1k 0.9×	696 0.6×	234 0.5×	71 0.2×	90	3.3k
Gulam Mustafa Hasan India	29	688 0.3×	1.4k 1.2×	613 0.5×	103 0.2×	142 0.3×	62	3.1k
Kiira Ratia United States	24	1.8k 0.8×	1.3k 1.1×	839 0.7×	282 0.6×	99 0.2×	41	3.3k
Burtram C. Fielding South Africa	26	2.9k 1.4×	922 0.8×	344 0.3×	295 0.7×	97 0.2×	53	4.0k
Ibrahim M. Ibrahim Egypt	27	495 0.2×	1.1k 1.0×	460 0.4×	220 0.5×	292 0.7×	153	3.1k
Sudeep Pushpakom United Kingdom	13	753 0.4×	1.6k 1.4×	898 0.8×	459 1.0×	82 0.2×	25	3.7k

Countries citing papers authored by Abdo A. Elfiky

Since Specialization

Citations

This map shows the geographic impact of Abdo A. Elfiky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdo A. Elfiky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdo A. Elfiky more than expected).

Fields of papers citing papers by Abdo A. Elfiky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdo A. Elfiky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdo A. Elfiky. The network helps show where Abdo A. Elfiky may publish in the future.

Co-authorship network of co-authors of Abdo A. Elfiky

This figure shows the co-authorship network connecting the top 25 collaborators of Abdo A. Elfiky. A scholar is included among the top collaborators of Abdo A. Elfiky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdo A. Elfiky. Abdo A. Elfiky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elfiky, Abdo A., et al.. (2025). GRP78 and cell-surface GRP78 self-association; In silico perspective. International Journal of Biological Macromolecules. 307(Pt 1). 141844–141844. 2 indexed citations

Abduljalil, Jameel M., Abdo A. Elfiky, & Maha AlKhazindar. (2024). Tepotinib and tivantinib as potential inhibitors for the serine/threonine kinase of the mpox virus: insights from structural bioinformatics analysis. Journal of Biomolecular Structure and Dynamics. 43(14). 7685–7695. 3 indexed citations

Elfiky, Abdo A., Florbela Pereira, Mariam I. Gamal El‐Din, et al.. (2024). Investigating the Structure–Activity Relationship of Laulimalides Marine Macrolides as Promising Inhibitors for SARS-CoV-2 Main Protease (Mpro). Journal of Computational Biophysics and Chemistry. 24(4). 403–419.

Elshemey, Wael M., et al.. (2024). Tackling SARS‐CoV‐2: Deep Purpose Virtual Screening Identified Compounds to Target the Glycosylated Full‐Length GRP78. Advanced Theory and Simulations. 7(10). 3 indexed citations

Elshemey, Wael M., et al.. (2024). Binding site prediction between lysozyme and glucose-regulated protein 78, a hope to fight amyloidosis. Journal of Biomolecular Structure and Dynamics. 43(18). 10358–10369. 3 indexed citations

Elfiky, Abdo A.. (2024). Prediction of the binding location between the nuclear inhibitor of DNA binding and differentiation 2 (ID2) and HSPA5. Pathology - Research and Practice. 255. 155217–155217. 3 indexed citations

Elfiky, Abdo A., et al.. (2024). Hybrid Virtual Screening Approach to Predict Novel Natural Compounds against HIV-1 CCR5. The Journal of Physical Chemistry B. 128(29). 7086–7101. 1 indexed citations

Abduljalil, Jameel M., et al.. (2023). Serine/threonine kinase of Mpox virus: computational modeling and structural analysis. Journal of Biomolecular Structure and Dynamics. 42(22). 12434–12445. 2 indexed citations

Fathy, Mohamed M., et al.. (2023). An insight into synthesis and antitumor activity of citrate and gallate stabilizing gold nanospheres. Scientific Reports. 13(1). 18 indexed citations

10.

Elfiky, Abdo A., et al.. (2023). Simulation of gold nanoparticle movement through normal and cancer cell membranes. Computers in Biology and Medicine. 164. 107363–107363. 5 indexed citations

11.

Elshemey, Wael M., et al.. (2023). A Computational Approach to Predict the Possible Binding Site of HCV NS5A and the Host Cell Chaperone, GRP78. Future Virology. 18(17). 1111–1121. 3 indexed citations

12.

Ibrahim, Ibrahim M., Abdo A. Elfiky, Sara H. Mahmoud, & Mahmoud ElHefnawi. (2023). A structural-based virtual screening and in vitro validation reveals novel effective inhibitors for SARS-CoV-2 helicase and endoribonuclease. Journal of Biomolecular Structure and Dynamics. 42(17). 9145–9158. 4 indexed citations

13.

Fu, Jiewen, et al.. (2023). New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19. Frontiers in Immunology. 14. 1166680–1166680. 31 indexed citations

14.

Renault, David, Abdo A. Elfiky, & Amr A. Mohamed. (2022). Predicting the insecticide-driven mutations in a crop pest insect: Evidence for multiple polymorphisms of acetylcholinesterase gene with potential relevance for resistance to chemicals. Environmental Science and Pollution Research. 30(7). 18937–18955. 6 indexed citations

15.

Abduljalil, Jameel M., et al.. (2022). In silicostructural elucidation of Nipah virus L protein and targeting RNA-dependent RNA polymerase domain by nucleoside analogs. Journal of Biomolecular Structure and Dynamics. 41(17). 8215–8229. 6 indexed citations

16.

Elfiky, Abdo A., et al.. (2021). GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective. Computers in Biology and Medicine. 139. 104956–104956. 15 indexed citations

17.

Ibrahim, Ibrahim M., et al.. (2019). GRP78: A cell's response to stress. Life Sciences. 226. 156–163. 474 indexed citations breakdown →

18.

Elfiky, Abdo A., et al.. (2019). Ebola Virus L Polymerase RdRp Sequence and Phylogenetic Analysis. 0(0). 29–36. 1 indexed citations

19.

Elfiky, Abdo A., Alaa M. Ismail, & Wael M. Elshemey. (2019). Recognition of gluconeogenic enzymes; Icl1, Fbp1, and Mdh2 by Gid4 ligase: A molecular docking study. Journal of Molecular Recognition. 33(5). e2831–e2831. 8 indexed citations

20.

Elfiky, Abdo A., et al.. (2016). Quantitative structure‐activity relationship and molecular docking revealed a potency of anti‐hepatitis C virus drugs against human corona viruses. Journal of Medical Virology. 89(6). 1040–1047. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact